Elsevier

Chemico-Biological Interactions

Volume 9, Issue 4, October 1974, Pages 285-315
Chemico-Biological Interactions

The orthomolecular treatment of cancer II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer

https://doi.org/10.1016/0009-2797(74)90019-2 Get rights and content

Abstract

This communication reports the clinical response of fifty consecutive advanced cancer patients to the continuous administration of large doses of ascorbic acid. It concludes that this simple and safe form of medication is of definite value in the palliation of terminal cancer. The findings suggest that it should be employed as a standard supportive measure to reinforce established methods of treatment in the general management of earlier and more favorable cases.

References (11)

There are more references available in the full text version of this article.

Cited by (254)

View all citing articles on Scopus

Supported by a Research Grant from the Secretary of State for Scotland.

a

Consultant Surgeon, Dunbartonshire Hospitals, and Fellow of the Institute of Orthomolecular Medicine. Address for reprints: Dr. Ewan Cameron FRCS, Vale of Leven District General Hospital, Alexandria, Dunbartonshire, G83 OUA (Scotland).

b

Consultant Physician, Lanarkshire Hospitals.

View full text